Dr. Hershock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
Hershey, PA 17033Phone+1 717-531-0003Fax+1 717-531-4969
Summary
- Dr. Diane Hershock is an oncologist now at Jefferson Northeast; previously affiliated with Penn State Milton S. Hershey Medical Center as well as Abramson Cancer Center at Penn. She received her medical degree from Sidney Kimmel Medical College and has been in practice 24 years. She specializes in head and neck oncology, melanoma and cutaneous malignancies, and gastrointestinal oncology. She has also been heavily involved in early drug development in industry and has been on several FDA submission teams.
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1996 - 1999
- Temple University HospitalResidency, Internal Medicine, 1993 - 1996
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1993
- Thomas Jefferson UniversityPh.D., Pharmacology, 1985 - 1989
- Saint Joseph's UniversityB.S., Biology, 1977 - 1981
Certifications & Licensure
- NJ State Medical License 2024 - 2025
- PA State Medical License 1994 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- University Teaching Assistantship Thomas Jefferson University, 1988
- National Research Service Award Cell Biology and Pathology, Thomas Jefferson University, 1987
- University Teaching Assistantship Thomas Jefferson University, College of Allied Health, Immunohematology, 1986
- Join now to see all
Clinical Trials
- BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Start of enrollment: 2002 Jan 01
Publications & Presentations
PubMed
- 13 citationsEffects of adinazolam on plasma catecholamine, heart rate and blood pressure responses in stressed and non-stressed ratsM. J. Krieman, Diane Hershock, I. J. Greenberg, Wolfgang H. Vogel
Neuropharmacology. 1992-01-01 - 1149 citationsCisplatin and fluorouracil alone or with docetaxel in head and neck cancer.Marshall R. Posner, Diane Hershock, Cesar R. Blajman, Elizabeth Mickiewicz, Eric Winquist
The New England Journal of Medicine. 2007-10-25 - 124 citationsMerkel cell carcinomaMichael S. Lehrer, Diane Hershock, Michael E. Ming
Current Treatment Options in Oncology. 2004-06-01
Journal Articles
- Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03)Machtay, M, Pajak, TF, Suntharalingam, M, Shenouda G, Hershock D, Stripp D, Cmelak AJ, Schulsinger, A, Fu KK, Int J Radiation Oncology, Biology, Physics, 1/1/2007
- Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerPosner, MR, Hershock D, Blajman CR et al, NEJM, 1/1/2007
- Percutaneous placement of an implantable arm port through an internal mammary venous pathway: case reportUrbania T, Hershock D, Clark TWI, J. Vascular Access, 1/1/2003
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Confirmation of the reliability and validity of Lung Cancer Symptom Scale (LCSS) forpPatients with malignant pleural mesothelioma: comparison of chemotherapy-pretreate...Arduino JM, Kindler HL, Hollen PJ, Sun X, Baas P, Bucci ME, Lubiniecki GM, Hershock DM, Krug LM, World Lung Conference, San Francisco, 7/1/2009
- A Phase III trial of docetaxel, cisplatin and 5-fluorouracil (TPF) versus cisplatin and 5-fluorouracil (PF) induction chemotherapy (IC) followed by chemoradiotherapy (...Posner, MR, Hershock D, Le-Lann L, Devlin, PM, Haddad RI, ASCO, 1/1/2006
- A phase I combination trial of fixed-dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer.Sun W, Theobald M, Hershock D, Haller DG, ASCO, 1/1/2004
- Join now to see all
Lectures
- "CTEP/NCI-cMet Program-Preclinical/Clinical Data to the Drug Development Group for Approval to Develop"Bethesda, MD - 12/1/2008
- "Chemical Carcinogenesis/Clinical Implications in Oncology"Graduate School, Thomas Jefferson University Hospital - 7/1/2008
- Grand Rounds: "Update on Head/Neck Cancers in the Community"Grandview Hospital - 12/1/2007
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: